acetylcysteine has been researched along with Hepatorenal Syndrome in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, J; Rana, R; Song, MY; Wang, SL; Xia, L; Yang, CQ | 1 |
| Burroughs, AK; Papastergiou, V; Tsochatzis, EA | 1 |
| Deray, G; Izzedine, H; Kheder-Elfekih, R; Thabut, D | 1 |
| Colle, I; Degré, D; Devière, J; Evrard, S; Hittelet, A; Langlet, P; Lasser, L; Le Moine, O; Lemmers, A; Moreno, C | 1 |
| Jalan, R; Mookerjee, RP; Sen, S | 1 |
| Burroughs, A; Fernando, B; Goodier, D; Harry, D; Holt, S; Marley, R; Moore, K; Patch, D | 1 |
2 review(s) available for acetylcysteine and Hepatorenal Syndrome
| Article | Year |
|---|---|
A prognostic evaluation and management of alcoholic hepatitis.
Topics: Acetylcysteine; Adrenal Cortex Hormones; Alcohol Abstinence; Bilirubin; Biomarkers; Biopsy; Combined Modality Therapy; Creatinine; Drug Substitution; Hepatitis, Alcoholic; Hepatorenal Syndrome; Humans; Liver; Liver Function Tests; Liver Transplantation; Models, Biological; Nutritional Support; Pentoxifylline; Prognosis; Risk Factors; Severity of Illness Index | 2017 |
Prognosis and treatment of patients with acute alcoholic hepatitis.
Topics: Acetylcysteine; Acute Disease; Adrenal Cortex Hormones; Antioxidants; Drug Resistance; Drug Therapy, Combination; Hepatitis, Alcoholic; Hepatorenal Syndrome; Humans; Liver Transplantation; Patient Selection; Pentoxifylline; Phosphodiesterase Inhibitors; Risk Factors; Severity of Illness Index; Treatment Outcome | 2014 |
1 trial(s) available for acetylcysteine and Hepatorenal Syndrome
| Article | Year |
|---|---|
Enteral nutrition with or without N-acetylcysteine in the treatment of severe acute alcoholic hepatitis: a randomized multicenter controlled trial.
Topics: Acetylcysteine; Adult; Combined Modality Therapy; Enteral Nutrition; Female; Free Radical Scavengers; Hepatitis, Alcoholic; Hepatorenal Syndrome; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Oxidative Stress; Single-Blind Method | 2010 |
3 other study(ies) available for acetylcysteine and Hepatorenal Syndrome
| Article | Year |
|---|---|
Endothelin-receptor antagonist/N-acetylcysteine combination in type 1 hepatorenal syndrome.
Topics: Acetylcysteine; Bosentan; Drug Therapy, Combination; Endothelin Receptor Antagonists; Free Radical Scavengers; Hepatorenal Syndrome; Humans; Male; Middle Aged; Sulfonamides; Treatment Outcome | 2009 |
Terlipressin-induced vasoconstriction reversed with N-acetylcysteine: a case for combined use in hepatorenal syndrome?
Topics: Acetylcysteine; Drug Therapy, Combination; Hepatorenal Syndrome; Humans; Lypressin; Terlipressin; Vasoconstriction; Vasoconstrictor Agents | 2002 |
Improvement in renal function in hepatorenal syndrome with N-acetylcysteine.
Topics: Acetylcysteine; Hepatorenal Syndrome; Humans; Kidney | 1999 |